Inside the Plant: How Cannabinoids Get Built

A jar, a loupe, and a fair question

What the light shows

Late evening, kitchen table. A jar of hemp flower sits under a phone torch held at an angle, and the surface looks frosted. Borrow a cheap loupe and the frost resolves into hundreds of small stalks with glassy heads. That is as close as the eye gets. Nobody has ever watched a cannabinoid being assembled. Everything we can say about the building work comes from proteins that have been isolated, named and measured, and it is worth holding that distinction before any chemistry starts.

Proteins with names and dates

Two publications carry most of this page. In 1996, Taura, Morimoto and Shoyama purified and described cannabidiolic-acid synthase from Cannabis sativa [2]. In 2012, Gagne and colleagues identified olivetolic acid cyclase in the same species [1]. Both are enzymes, which means proteins that take one molecule and hand back another in a fixed, repeatable way. Neither paper describes a plant with intentions. They describe characterised proteins doing measurable chemistry, and that is the only kind of statement worth building on. Names, years, species: those three things separate a pathway from a story.

From olivetolic acid to CBGA

One arrow, two molecules. Olivetolic acid goes in, CBGA comes out [1]. Chemists spent a long time on that arrow, because olivetolic acid has to be built and its ring closed before anything recognisably cannabinoid exists in the plant at all. The 2012 study by Gagne and colleagues identified the enzyme responsible for that ring closure, olivetolic acid cyclase, working in Cannabis sativa [1]. A cyclase is a ring-maker: it takes a chain and joins it into a closed loop. Once CBGA exists, the route can branch toward the individual acids that lab reports later list by name.

Why the 2012 route was noteworthy

Polyketides are a large family of plant compounds built by stacking small carbon units, like beads on a thread, then folding the result. Plants make thousands of them, and the enzymes involved follow fairly familiar patterns. The catalytic route described for Cannabis sativa in 2012 does not follow those patterns closely, which is what makes it unusual among plant polyketides [1]. Hemp, in other words, arrives at its starting cannabinoid by a route of its own.

The pathway as a numbered sequence

1. Everything the living plant assembles along this route carries an acid group. The A in CBGA and CBDA is part of the chemistry, not a typographical quirk on an analysis.
2. Olivetolic acid sits at the front of the section covered by the 2012 work, and the ring-closing enzyme that acts on it was identified in Cannabis sativa [1].
3. CBGA is the product of that step [1]. From there, the route divides toward the separate acids that give a cultivar its profile.
4. Cannabidiolic-acid synthase is the protein named for one of those branches. It was purified from Cannabis sativa and characterised in 1996 [2].
5. The finished acids are not transported [2]. Whatever the tissue builds, the tissue keeps, which is why the resin heads on that flower matter more than the leaf around them.
6. Each step above has a protein behind it, with a species, a year and a method attached. That is the standard we read this topic by, and it rules out a lot of confident-sounding material found elsewhere.

What the two papers establish, and what they leave open

1. Taura, Morimoto and Shoyama, 1996: cannabidiolic-acid synthase purified and characterised from Cannabis sativa [2]. Purified means separated from everything else in the tissue, so the activity measured belongs to that protein and nothing hiding beside it.
2. Gagne and colleagues, 2012: olivetolic acid cyclase identified in Cannabis sativa, with olivetolic acid converted onward to CBGA [1].
3. The 2012 paper also places that chemistry in context, describing the catalytic route as unusual among plant polyketides [1]. It is a statement about how, not about how much.
4. On the movement question, the 1996 record is plain: no transport of the finished acids [2].
5. Neither paper puts a figure on what a particular crop yields, and neither concerns itself with what any preparation does in a person. Both are laboratory studies of characterised proteins.
6. Read together, they cover a defined stretch of the route. Other steps and other synthases exist in the wider literature, and we would rather name the two we can cite precisely than gesture at all of it.

Where this meets a batch report

The practical consequence turns up on paper. A cannabinoid analysis lists acid and neutral forms on separate lines, so CBDA and CBD are counted as two entries rather than one, and a total that quietly merges them tells you less. Working with cannabinoids since 2014 has made one thing clear in our own lab work: the variable that decides which acids a batch carries sits in the plant and its enzymes, not in the extraction method chosen afterwards. Extraction moves compounds out of plant material. It does not decide which ones the plant built in the first place.

Two lines, one plant

So when a report shows CBDA alongside CBD, that is not a printing accident. It is the plant's own chemistry on one line and what happened to that material afterwards on the next. Our analyses are published per batch, which is the only way to check a number instead of accepting it. Claims are cheap. Reports are checkable, and a bottle either matches its own or it does not.

Reading a hemp label with the pathway in mind

1. Look for the acid and neutral entries as separate lines on the analysis, rather than a single combined cannabinoid figure.
2. Check which species the source material is. Both cited papers worked with Cannabis sativa [1][2].
3. Remember that a report measures compounds, not enzymes. Olivetolic acid cyclase and cannabidiolic-acid synthase belong in the literature, not in a certificate column [1][2].
4. Read the report that belongs to the batch code on your bottle, not a generic example from a product page.
5. THC status should be stated plainly: our products stay within legal limits and are non-intoxicating.
6. If a source explains cannabinoid building without naming a protein, a year and a species, it is offering you less than the 1996 and 2012 papers already put in print [1][2].